Psychological Burden in Relapsing-Remitting Multiple Sclerosis: Sociodemographic and Clinical Determinants of Persistent Anxiety and Depression over a Six-Month Follow-Up
Authors:
- María Lourdes Bermello LópezMLMaría Lourdes Bermello López
- Emilio Rubén Pego PérezEPEmilio Rubén Pego Pérez
- Eva Gómez FernándezEFEva Gómez Fernández
- María del Rosario Marín ArnésMAMaría del Rosario Marín Arnés
- Mercedes Fernández VázquezMVMercedes Fernández Vázquez
- María Irene Núñez HernándezMHMaría Irene Núñez Hernández
- Emilio Gutiérrez GarcíaEGEmilio Gutiérrez García
Open Access
- 26 January 2026
- journal article
- research article
- Published by MDPI AG in Nursing Reports
- Vol. 16 (2) , 39
Abstract
Background/Objectives: Multiple sclerosis (MS) is a chronic neurological disease characterized by demyelination, inflammation, and autoimmunity, leading to progressive physical and psychological impairments. Anxiety and depression are among the most prevalent neuropsychiatric comorbidities in MS, significantly impacting patients’ quality of life (QoL). This study aimed to assess the evolution of anxiety and depression in individuals with relapsing-remitting multiple sclerosis (RRMS) over a six-month follow-up period, identify associated factors, and explore potential predictors of these psychological conditions. Methods: A prospective observational study was conducted with 35 RRMS patients diagnosed at the Lucus Augusti University Hospital between January 2023 and March 2025. Psychological symptoms were assessed at baseline, after 3 months, and after 6 months using the Goldberg Anxiety and Depression Scale (GADS), the Beck Depression Inventory (BDI), and the Beck Anxiety Inventory (BAI). Data were analyzed using non-parametric tests to account for the small sample size and non-normal distribution of variables. Results: Anxiety and depression were prevalent and persistent in the study population, with no significant changes in mean scores over time (p > 0.05). However, specific symptoms, such as pessimism and loss of pleasure, showed worsening trends, while sadness and guilt remained stable. Sociodemographic factors, including lower income and employment status, were significantly associated with higher anxiety and depression scores (p < 0.05). Additionally, clinical factors such as autoimmune comorbidities and a history of mononucleosis were linked to higher depressive symptoms. Baseline anxiety and depression scores emerged as strong predictors of future levels (p < 0.01), emphasizing the importance of early assessments. Conclusions: Anxiety and depression are prevalent and persistent in RRMS patients, with specific symptoms fluctuating over time. Sociodemographic and clinical factors play a significant role in psychological outcomes, highlighting the need for integrated care models that address both physical and psychosocial aspects of MS. Early psychological assessments and targeted interventions are critical for improving QoL and mitigating the long-term burden of mental health challenges in RRMS.Keywords
All Related Versions
Funding Information
- Ilustre Colegio Oficial de Enfermería de Lugo and University of Santiago de Compostela (2025-PO021)
This publication has 76 references indexed in Scilit:
- Health Care Affordability Problems by Income Level and Subsidy Eligibility in MedicareJAMA Network Open, 2025
- Quality of life and access to treatment for patients with multiple sclerosis during economic crisis: the Lebanese experienceQuality of Life Research, 2025
- Depression and anxiety in multiple sclerosis. Review of a fatal combinationJournal of Neural Transmission, 2024
- Improved quality of life and psychological symptoms following mindfulness and cognitive rehabilitation in multiple sclerosis and their mediating role for cognition: a randomized controlled trialJournal of Neurology, 2024
- Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based studyJournal of Neurology, 2023
- Characterization of Depression- and Anxiety-Like Behaviours in a Mouse Model of Relapsing-Remitting Multiple SclerosisJournal of Neuroimmune Pharmacology, 2023
- The manifestation of affective symptoms in multiple sclerosis and discussion of the currently available diagnostic assessment toolsJournal of Neurology, 2022
- Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemicNeurological Sciences, 2022
- Depression, anxiety, and fear of COVID-19 in patients with multiple sclerosis in pandemic era: a cross-sectional studyNeurological Sciences, 2021
- Environmental and genetic risk factors for MS: an integrated reviewAnnals of Clinical and Translational Neurology, 2019